MyD88 signaling causes autoimmune sialadenitis through formation of high endothelial venules and upregulation of LTβ receptor-mediated signaling
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MyD88 signaling causes autoimmune sialadenitis through formation of high endothelial venules and upregulation of LTβ receptor-mediated signaling ; volume:8 ; number:1 ; day:24 ; month:9 ; year:2018 ; pages:1-12 ; date:12.2018
Scientific reports ; 8, Heft 1 (24.9.2018), 1-12, 12.2018
- Urheber
-
Into, Takeshi
- Beteiligte Personen und Organisationen
-
Niida, Shumpei
Shibata, Ken-ichiro
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-32690-x
- URN
-
urn:nbn:de:101:1-2018110415063884392435
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Into, Takeshi
- Niida, Shumpei
- Shibata, Ken-ichiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Uropathogenic Escherichia coli block MyD88 dependent and activate MyD88 independent signaling pathways in rat testicular cells
Blocking MyD88 signaling with MyD88 inhibitor prevents colitis-associated colorectal cancer development by maintaining colonic microbiota homeostasis
Modeling MyD88 deficiency
MyD88 mutations in B cell tumors : constitutive signaling by TIR domain oligomerization
Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells
MyD88 as a potential target of redox regulation within the NF-κB signaling pathway
Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells
Oxytocin Receptor-Mediated Signaling in Astrocytes
MyD88 signaling in dendritic cells and the intestinal epithelium controls immunity against intestinal infection with C. rodentium
Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
Immunmodulation der intestinalen Karzinogenese durch das Immun-Adapterprotein MyD88
Uropathogenic Escherichia coli block MyD88 dependent and activate MyD88 independent signaling pathways in rat testicular cells
Blocking MyD88 signaling with MyD88 inhibitor prevents colitis-associated colorectal cancer development by maintaining colonic microbiota homeostasis
Modeling MyD88 deficiency
MyD88 mutations in B cell tumors : constitutive signaling by TIR domain oligomerization
Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells
MyD88 as a potential target of redox regulation within the NF-κB signaling pathway
Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells
Oxytocin Receptor-Mediated Signaling in Astrocytes
MyD88 signaling in dendritic cells and the intestinal epithelium controls immunity against intestinal infection with C. rodentium
Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
Immunmodulation der intestinalen Karzinogenese durch das Immun-Adapterprotein MyD88
Uropathogenic Escherichia coli block MyD88 dependent and activate MyD88 independent signaling pathways in rat testicular cells
Blocking MyD88 signaling with MyD88 inhibitor prevents colitis-associated colorectal cancer development by maintaining colonic microbiota homeostasis
Modeling MyD88 deficiency
MyD88 mutations in B cell tumors : constitutive signaling by TIR domain oligomerization
Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells
MyD88 as a potential target of redox regulation within the NF-κB signaling pathway
Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells
Oxytocin Receptor-Mediated Signaling in Astrocytes
MyD88 signaling in dendritic cells and the intestinal epithelium controls immunity against intestinal infection with C. rodentium
Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation